PAM-OBG: A Monoamine Oxidase B Specific Prodrug That Inhibits MGMT and Generates DNA Interstrand Crosslinks, Potentiating Temozolomide and Chemoradiation Therapy in Intracranial Glioblastoma
Oncotarget - United States
doi 10.18632/oncotarget.25246
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 16, 2018
Authors
Publisher
Impact Journals, LLC